Purple Biotech Ltd.
Develops cancer therapies to overcome tumor immune evasion and drug resistance.
PPBT | TA
Overview
Corporate Details
- ISIN(s):
- IL0007650166
- LEI:
- Country:
- Israel
- Address:
- Oppenheimer 4, 7670104 Rehovot
- Website:
- https://purple-biotech.com/
- Sector:
- Manufacturing
Description
Purple Biotech Ltd. is a clinical-stage company that develops first-in-class therapies for cancer patients. The company focuses on advancing treatments designed to overcome tumor immune evasion and drug resistance, with the goal of providing effective and durable therapeutic solutions.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2020-11-12 16:46 |
KITOV PHARMA COMPANY PRESENTATION NOVEMBER 2020
|
English | 9.5 MB | ||
| 2020-11-12 16:46 |
KITOV PHARMA COMPANY PRESENTATION NOVEMBER 2020
|
English | 36.5 KB | ||
| 2020-11-09 15:39 |
Kitov Expands Planned Phase 1/2 Clinical Trial of CM24 in Non-Small Cell Lung C…
|
English | 143.8 KB | ||
| 2020-11-09 15:39 |
Kitov Expands Planned Phase 1/2 Clinical Trial of CM24 in Non-Small Cell Lung C…
|
English | 36.7 KB | ||
| 2020-10-27 17:37 |
6k: Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its An…
|
English | 149.0 KB | ||
| 2020-10-27 17:37 |
6k: Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its An…
|
English | 36.6 KB | ||
| 2020-10-27 15:18 |
Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its Anti-C…
|
English | 52.6 KB | ||
| 2020-10-27 15:18 |
Kitov Pharma Receives Notice of Allowance for a U.S. Patent Covering its Anti-C…
|
English | 36.5 KB | ||
| 2020-10-25 01:22 |
Annual General Meeting of Shareholders to be held on December 3, 2020
|
English | 152.6 KB | ||
| 2020-10-25 01:22 |
Annual General Meeting of Shareholders to be held on December 3, 2020
|
English | 1.3 MB | ||
| 2020-10-25 01:22 |
Annual General Meeting of Shareholders to be held on December 3, 2020
|
English | 97.2 KB | ||
| 2020-10-25 01:15 |
Annual General Meeting of Shareholders to be held on December 3, 2020
|
English | 1.3 MB | ||
| 2020-10-25 01:15 |
Annual General Meeting of Shareholders to be held on December 3, 2020
|
English | 36.5 KB | ||
| 2020-10-18 10:41 |
PR: New Mechanism of Action Data for NT219 Presented at Epigenetics and Metabol…
|
English | 165.0 KB | ||
| 2020-10-18 10:41 |
PR: New Mechanism of Action Data for NT219 Presented at Epigenetics and Metabol…
|
English | 36.6 KB |
Automate Your Workflow. Get a real-time feed of all Purple Biotech Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Purple Biotech Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Purple Biotech Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
